Sargent Bickham Lagudis LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 189 filers reported holding CRISPR THERAPEUTICS AG in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.6%.

Quarter-by-quarter ownership
Sargent Bickham Lagudis LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q4 2022$7,276
-9.0%
179
+38.8%
0.00%0.0%
Q3 2022$8,0000.0%1290.0%0.00%0.0%
Q2 2022$8,0000.0%1290.0%0.00%0.0%
Q1 2022$8,000
-20.0%
1290.0%0.00%0.0%
Q4 2021$10,000
+150.0%
129
+303.1%
0.00%
Q3 2021$4,000
-20.0%
320.0%0.00%
Q2 2021$5,000
+25.0%
320.0%0.00%
Q1 2021$4,000
-55.6%
32
-50.0%
0.00%
Q4 2020$9,000
+200.0%
64
+100.0%
0.00%
Q3 2020$3,000
+50.0%
320.0%0.00%
Q2 2020$2,000
+100.0%
320.0%0.00%
Q1 2020$1,000
-50.0%
320.0%0.00%
Q4 2019$2,000
+100.0%
320.0%0.00%
Q3 2019$1,000
-50.0%
320.0%0.00%
Q2 2019$2,000
+100.0%
320.0%0.00%
Q1 2019$1,0000.0%320.0%0.00%
Q4 2018$1,0000.0%320.0%0.00%
Q3 2018$1,000
-50.0%
320.0%0.00%
Q2 2018$2,000320.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$37,781,00020.21%
Ariose Capital Management Ltd 37,900$2,872,0006.78%
EcoR1 Capital, LLC 1,077,483$81,652,0002.60%
NEA Management Company, LLC 1,590,002$120,490,0002.44%
ARK Investment Management 9,087,868$688,679,0002.08%
NIA IMPACT ADVISORS, LLC 62,609$3,876,0002.06%
Deuterium Capital Management, LLC 18,000$1,364,0002.02%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,200$8,192,0001.82%
PLUSTICK MANAGEMENT LLC 50,000$3,789,0001.76%
Nikko Asset Management Americas, Inc. 4,319,471$330,526,0001.74%
View complete list of CRISPR THERAPEUTICS AG shareholders